Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Considering Obesity Drug Coverage Under Medicare Rx Benefit

Executive Summary

The Centers for Medicare & Medicaid Services is seeking comment on how obesity treatments can be covered under the Medicare Rx benefit despite language in the law that prohibits coverage of "weight loss" drugs

You may also be interested in...



Sanofi-Aventis Expects Broad Label For Acomplia After FDA Obesity Panel

Sanofi-Aventis is interpreting the results of FDA's recent Endocrinologic & Metabolic Drugs Advisory committee on obesity drug development as a sign that its obesity/smoking cessation agent Acomplia will be approved with a broad label

Sanofi-Aventis Expects Broad Label For Acomplia After FDA Obesity Panel

Sanofi-Aventis is interpreting the results of FDA's recent Endocrinologic & Metabolic Drugs Advisory committee on obesity drug development as a sign that its obesity/smoking cessation agent Acomplia will be approved with a broad label

Acomplia Pricing Likely To Follow Statin Model, Sanofi Says

Sanofi is likely to price the weight loss/smoking cessation agent Acomplia on par with the daily cost of statin therapy, the company suggested during an Aug. 31 analyst call

Related Content

Topics

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel